With Medicare spending projected to reach $2 trillion by 2032, getting the cost story right matters. But for policymakers and staff, that is easier said than done. Research comparing Medicare Advantage (MA) and Traditional Medicare (TM) often appears to point in different directions, but the differences often reflect different research method choices, different definitions, and different underlying policy questions.
This resource is designed to help policymakers cut through that confusion and interpret studies evaluating MA and TM with a more critical eye.
The guide offers policymakers:
- A framework for understanding how researchers define “cost” and “value” differently depending on what they are trying to measure.
- A side-by-side comparison of four major 2024–2025 studies to show why they reach different conclusions.
- Plain-language explanations of key terms and concepts like risk adjustment, coding intensity, and favorable selection—the technical fault lines that shape this debate.
Nine simple, yet concrete questions to assess whether a new study actually answers the policy question the policymaker hopes to address.